Does nurse case management improve implementation of guidelines for cardiovascular disease risk reduction?

Journal of Cardiovascular Nursing

Volumn 26, Issue 2, 2011, Pages 145-167

  Berra, Kathy ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

case management; literature review; modifiable cardiovascular risk factors; nurse

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CASE MANAGEMENT; DISEASE MANAGEMENT; DYSLIPIDEMIA; HUMAN; LIFESTYLE; NURSE ATTITUDE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; STATISTICS;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE MANAGEMENT; DISEASE MANAGEMENT; DYSLIPIDEMIAS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIFE STYLE; NURSE'S ROLE; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING CESSATION;

EID: 79951947972     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e3181ec1337     Document Type: Review

References (164)

1. Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003;107(11): 1562-1566. (Pubitemid 36378499)
2. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113(19):2363-2372.
3. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007;28(19): 2375-2414.
4. World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment andManagement of Total Cardiovascular Risk. Geneva, Switzerland: WHO; 2007.
5. Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
6. Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes About Cardiovascular Treatment (REACT) survey. Fam Pract. 2002;19(6):596-604. (Pubitemid 35460642)
7. Fonarow GC, Yancy CW, Heywood JT. Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. Arch Intern Med. 2005;165(13):1469-1477. (Pubitemid 41058026)
8. World Health Organization. Adherence to long-term therapies: evidence for action. WHO. http://www.who. int/chp/knowledge/publications/adherence-report/ en/ index.html. Accessed December 4, 2008.
9. Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165(10):1147-1152. (Pubitemid 40720739)
10. Ho PM, Magid DJ, Shetterly SM, et al. Medication non-adherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772-779. (Pubitemid 351410514)
11. Greenland P. Closing the treatment gap: in the community and at hospital discharge. Am J Med. 1996;101(4A): 4A76S-4A78S.
12. Stafford RS, Berra K. Critical factors in case management: practical lessons from a cardiac case management program. Dis Manag. 2007;10(4):197-207. (Pubitemid 47403495)
13. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994;89(3):975-990. (Pubitemid 24076521)
14. Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol. 2001; 87(7):819-822. (Pubitemid 32244197)
15. Wood DA, Kotseva K, Connolly S, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet. 2008;371(9629): 1999-2012. (Pubitemid 351799857)
16. DeBusk RF, Miller NH, Superko HR, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med. 1994;120(9):721-729.
17. Fletcher B, Berra K, Ades P, et al. Managing abnormal blood lipids: a collaborative approach. Circulation. 2005; 112(20):3184-3209. (Pubitemid 43113447)
18. Berra K. Treatment options for patients with the metabolic syndrome. J Am Acad Nurse Pract. 2003;15(8):361-370.
19. Berra K. Lipid-lowering therapy today: treating the high-risk cardiovascular patient. J Cardiovasc Nurs. 2008; 23(5):414-421.
20. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2-4.
21. Berra K, Miller NH, Fair JM. Cardiovascular disease prevention and disease management: a critical role for nursing. J Cardiopulm Rehabil. 2006;26(4):197-206. (Pubitemid 44641513)
22. Thomas TS. Improving care with nurse case managers: practical aspects of designing lipid clinics. Am J Cardiol. 1997;80(8B):62H-65H.
23. Dunbar SB, Mensah GA, Labarthe DR. Building bridges: a partnership between professional nursing and the Centers for Disease Control and Prevention to reduce the burden of heart disease and stroke. Am J Prev Med. 2005; 29(5 suppl 1):122-127. (Pubitemid 43024121)
24. Allison TG, Squires RW, Johnson BD, Gau GT. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy. Mayo Clin Proc. 1999;74(5):466-473.
25. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89(3):1333-1445.
26. Allen JK, Blumenthal RS, Margolis S, Young DR, Miller ER 3rd, Kelly K. Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial. Am Heart J. 2002; 144(4):678-686.
27. Ryan MJ Jr, Gibson J, Simmons P, Stanek E. Effectiveness of aggressive management of dyslipidemia in a collaborative-care practice model. Am J Cardiol. 2003; 91(12):1427-1431. (Pubitemid 36694718)
28. National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
29. Pollock ML, Franklin BA, Balady GJ, et al. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: an advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation. 2000;101(7):828-833.
30. Gemson DH, Commisso R, Fuente J, Newman J, Benson S. Promoting weight loss and blood pressure control at work: impact of an education and intervention program. J Occup Environ Med. 2008;50(3):272-281. (Pubitemid 351372071)
31. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572. (Pubitemid 37430158)
32. Tobe SW, Pylypchuk G, Wentworth J, et al. Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial. CMAJ. 2006; 174(9):1267-1271.
33. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care. 1998;21(1): 179-182.
34. Meltzer S, Leiter L, Daneman D, et al. 1998 Clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ. 1998;159(suppl 8): S1-S29.
35. Taylor CB, Houston-Miller N, Killen JD, DeBusk RF. Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention. Ann Intern Med. 1990;113(2):118-123. (Pubitemid 20218629)
36. Taylor CB, Miller NH, Herman S, et al. A nurse-managed smoking cessation program for hospitalized smokers. Am J Public Health. 1996;86(11):1557-1560. (Pubitemid 26389213)
37. Sidorov J, Christianson M, Girolami S, Wydra C. A successful tobacco cessation program led by primary care nurses in a managed care setting. Am J Manag Care. 1997;3(2):207-214.
38. Smith PM, Reilly KR, Houston Miller N, DeBusk RF, Taylor CB. Application of a nurse-managed inpatient smoking cessation program. Nicotine Tob Res. 2002;4(2): 211-222. (Pubitemid 34679848)
39. Strömberg A, Märtensson J, Fridlund B, Levin LA, Karlsson JE, Dahlström U. Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial. Eur Heart J. 2003;24(11):1014-1023. (Pubitemid 36712277)
40. Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J. 1997;18(5):736-753.
41. Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards. A statement for healthcare professionals from the American Heart Association Writing Group. Circulation. 1995; 91(2):580-615.
42. Tolonen H, Keil U, Ferrario M, Evans A. Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project. Int J Epidemiol. 2005;34(1):181-192. (Pubitemid 40347392)
43. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol. 2008;52(22):1769-1781.
44. Sever PS, Dahlöf B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOTLLA): a multicentre randomised controlled trial. Lancet. 2003;361(9364):1149-1158. (Pubitemid 36398384)
45. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326): 7-22.
46. 4S Investigators. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344(8934):1383-1389.
47. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333(20):1301-1307.
48. Mason CM. The nurse practitioner's role in helping patients achieve lipid goals with statin therapy. J Am Acad Nurse Pract. 2005;17(7):256-262.
49. Allen JK. Cholesterol management: an opportunity for nurse case managers. J Cardiovasc Nurs. 2000;14(2): 50-58.
50. Mason CM. Managing the spectrum of dyslipidemia in primary care. J Vasc Nurs. 2003;21(3):81-89; quiz 90-81.
51. Mason CM. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model. J Am Acad Nurse Pract. 2009;21(1):47-53.
52. Cofer LA. Aggressive cholesterol management: role of the lipid nurse specialist. Heart Lung. 1997;26(5):337-344. (Pubitemid 27408592)
53. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217- 223. (Pubitemid 40138015)
54. Sever PS, Poulter NR, Dahlöf B, et al. The Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm: extended observations 2 years after trial closure. Eur Heart J. 2008;29(4):499-508. (Pubitemid 351264177)
55. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997.
56. Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895-906. (Pubitemid 41265663)
57. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362(9395):1527-1535. (Pubitemid 37410190)
58. Wong ND, Lopez V, Tang S, Williams GR. Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States. Am J Cardiol. 2006;98(2):204-208. (Pubitemid 43996906)
59. Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens. 2004;18(8): 545-551. (Pubitemid 39173530)
60. Antikainen RL, Moltchanov VA, Chukwuma C Sr, et al. Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovasc Prev Rehabil. 2006;13(1):13-29.
61. WHO Tobacco Free Initiative. Building Blocks for Tobacco Control: A Handbook. Geneva, Switzerland: World Health Organization; 2004.
62. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): casecontrol study. Lancet. 2004;364(9438):937-952. (Pubitemid 39208455)
63. Centers for Disease Control and Prevention. Cigarette smoking among adults - United States, 2000. MMWR Morb Mortal Wkly Rep. 2002;51:642.
64. Zhu S, Melcer T, Sun J, Rosbrook B, Pierce JP. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med. 2000;18(4):305-311. (Pubitemid 30224565)
65. World Health Organization. Obesity and overweight. September 2006. http://www.who.int/mediacentre/factsheets/ fs311/en/index.html. Accessed March 5 2009.
66. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000; 343(1):16-22. (Pubitemid 30447987)
67. Fair JM, Berra K. Life-style changes and coronary heart disease: the influence of nonpharmacologic interventions. J Cardiovasc Nurs. 1995;9(2):12-24.
68. Berra K. The effect of lifestyle interventions on quality of life and patient satisfaction with health and health care. J Cardiovasc Nurs. 2003;18(4):319-325.
69. Taylor CB, Coffey T, Berra K, Iaffaldano R, Casey K, Haskell WL. Seven-day activity and self-report compared to a direct measure of physical activity. Am J Epidemiol. 1984;120(6):818-824. (Pubitemid 15216796)
70. Erhardt L, Moller R, García Puig J. Comprehensive cardiovascular risk management-what does it mean in practice? Vasc Health Risk Manag. 2007;3(5):587-603.
71. Kostis JB. The importance of managing hypertension and dyslipidemia to decrease cardiovascular disease. Cardiovasc Drugs Ther. 2007;21(4):297-309. (Pubitemid 47387466)
72. National Cholesterol Education Program. Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Washington, DC: National Institutes of Health; 1989. DHSS Publication NIH 89-2925.
73. European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.J Hypertens. 2003;21(6): 1011-1053.
74. West JA, Miller NH, Parker KM, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol. 1997;79(1):58-63. (Pubitemid 127673677)
75. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987;257(23):3233-3240. (Pubitemid 17078320)
76. Konstam M, Dracup K, Baker DW, et al. Heart Failure: Evaluation and Care of Patients With Left-Ventricular Systolic Dysfunction. Clinical Practice Guideline No. 11. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services; 1994.
77. Gunnar RM, Bourdillon PD, Dixon DW, et al. ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction). Circulation. 1990;82(2):664-707. (Pubitemid 20257857)
78. LaBresh KA, Ellrodt AG, Gliklich R, Liljestrand J, Peto R. Get With the Guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med. 2004;164(2): 203-209. (Pubitemid 38140408)
79. LaBresh KA, Reeves MJ, Frankel MR, Albright D, Schwamm LH. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With the Guidelines" program. Arch Intern Med. 2008; 168(4):411-417.
80. Fonarow GC, LaBresh KA, Yancy C, et al. Influence of the American Heart Association's Get With the Guidelines Heart Failure (GWTG-HF) program on emerging performance measures for patients hospitalized with heart failure [abstract]. Circulation. 2006;114(18):572.
81. Smith SC Jr, Blair SN, Criqui MH, et al. Preventing heart attack and death in patients with coronary disease. Circulation. 1995;92(1):2-4.
82. Smith SC Jr, Blair SN, Criqui MH, et al. AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol. 1995;26(1):292-294.
83. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/ American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37(2): 577-617. (Pubitemid 43732031)
84. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154-e235.
85. Campbell NC, Ritchie LD, Thain J, Deans HG, Rawles JM, Squair JL. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart. 1998;80(5):447-452. (Pubitemid 28535530)
86. Murchie P, Campbell NC, Ritchie LD, Simpson JA, Thain J. Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care. BMJ. 2003;326(7380):84.
87. Sever P, Beevers G, Bulpitt C, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ. 1993; 306(6883):983-987. (Pubitemid 23100026)
88. Bain NS, Foster K, Grimshaw J, et al. Can audit of a local protocol for the management of lipid disorders effect and detect a change in clinical practice? Health Bull (Edinb). 1997;55(2):94-102.
89. Blue L, Lang E, McMurray JJ, et al. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ. 2001;323(7315):715-718. (Pubitemid 32929432)
90. Stewart S, Blue L. Improving Outcomes in Chronic Heart Failure: Specialist Nurse Intervention From Research to Practice. 1st ed. London, UK: BMJ Publishing Group; 2001.
91. Eagle KA, Montoye CK, Riba AL, et al. Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) Projects in Michigan. J Am Coll Cardiol. 2005;46(7):1242-1248. (Pubitemid 41615544)
92. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996; 28(5):1328-1428. (Pubitemid 26377013)
93. Laprise R, Thivierge R, Gosselin G, et al. Improved cardiovascular prevention using best CME practices: a randomized trial. J Contin Educ Health Prof. 2009;29(1):16-31.
94. Harris SB, Lank CN. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors. Can Fam Physician. 2004;50: 425-433.
95. Genest J, Frohlich J, Fodor G, McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ. 2003;169(9):921-924.
96. Stone JA, Arthur HM. Canadian Guidelines for Cardiac Rehabilitation and Cardiovascular Disease Prevention, second edition, 2004: executive summary. Can J Cardiol. 2005;21(suppl D):3D-19D.
97. Creager MA, Goldstone J, Hirshfeld JW Jr, et al. ACC/ ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions. A report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS writing committee to develop a clinical competence statement on peripheral vascular disease). Vasc Med. 2004;9(3):233-248.
98. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. (Pubitemid 34437694)
99. National Cholesterol Education Program. Step by Step: Eating to Lower Your High Blood Cholesterol. Bethesda, MD: NCEP; 1987.
100. New JP, Mason JM, Freemantle N, et al. Specialist Nurse-Led Intervention to Treat and Control Hypertension and Hyperlipidemia In Diabetes (SPLINT): a randomized controlled trial. Diabetes Care. 2003;26(8):2250-2255. (Pubitemid 36993308)
101. Department of Health. National Service Framework for Diabetes: Standards. London: Diabetes NSF Team, Department of Health; 2002:45.
102. Ma J, Berra K, Haskell WL, et al. Case management to reduce risk of cardiovascular disease in a county health care system. Arch Intern Med. 2009;169(21):1988-1995.
103. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106(3):388-391.
104. Maron DJ, Boden WE, O'Rourke RA, et al. Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. J Am Coll Cardiol. 2010;55(13): 1348-1358.
105. Guidelines for the Evaluation and Management of Heart Failure. Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol. 1995;26(5):1376-1398.
106. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227-239. (Pubitemid 38924592)
107. Mochari H, Gao Q, Mosca L. Validation of the MEDFICTS dietary assessment questionnaire in a diverse population. J Am Diet Assoc. 2008;108(5):817-822. (Pubitemid 351602058)
108. Calfas KJ, Long BJ, Sallis JF, Wooten WJ, Pratt M, Patrick K. A controlled trial of physician counseling to promote the adoption of physical activity. Prev Med. 1996; 25(3):225-233. (Pubitemid 126335233)
109. Fonarow GC, AbrahamWT, Albert NM, et al. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med. 2007;167(14):1493-1502. (Pubitemid 47134697)
110. Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297(1):61-70. (Pubitemid 46041727)
111. Hong Y, LaBresh KA. Overview of the American Heart Association "Get With the Guidelines" programs: coronary heart disease, stroke, and heart failure. Crit Pathw Cardiol. 2006;5(4):179-186.
112. DeBusk RF, Miller NH, Parker KM, et al. Care management for low-risk patients with heart failure: a randomized, controlled trial. Ann Intern Med. 2004;141(8): 606-613. (Pubitemid 39390538)
113. Flynn FM, Cafarelli M, Petrakos K, Christophersen P. Improving outcomes for acute coronary syndrome patients in the hospital setting: successful implementation of the American Heart Association "Get With the Guidelines" program by phase I cardiac rehabilitation nurses. J Cardiovasc Nurs. 2007;22(3):166-176.
114. Lewis WR, Peterson ED, Cannon CP, et al. An organized approach to improvement in guideline adherence for acute myocardial infarction: results with the GetWith the Guidelines quality improvement program. Arch Intern Med. 2008;168(16):1813-1819.
115. Nancy MA, Kimberly KB, Christopher PC, et al. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines Database). Am J Cardiol. 2008;101(9):1242-1246.
116. Krantz MJ, Baker WA, Estacio RO, et al. Comprehensive coronary artery disease care in a safety-net hospital: results of Get With the Guidelines quality improvement initiative. J Manag Care Pharm. 2007;13(4):319-325. (Pubitemid 46958751)
117. Patel UD, Hernandez AF, Liang L, et al. Quality of care and outcomes among patients with heart failure and chronic kidney disease: a Get With the Guidelines-Heart Failure Program study. Am Heart J. 2008;156(4): 674-681.
118. Jackson S, Morgan G. Change of heart. How a team of North Kirklees primary care trust clinicians used performance management principles to improve coronary heart disease services. Int J Health Care Qual Assur. 2007;20(1):61-76.
119. World Health Organization. Diabetes Action Now: an initiative of the World Health Organization and the International Diabetes Federation. World Health Organization [pdf]. http://www.who.int/diabetes/actionnow/en/ DANbooklet.pdf. Accessed November 27, 2008.
120. Blonde L, Dempster J, Gallivan JM, Warren-Boulton E. Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program. J Am Acad Nurse Pract. 2006;18(11):524-533.
121. Krein SL, Klamerus ML, Vijan S, et al. Case management for patients with poorly controlled diabetes: a randomized trial. Am J Med. 2004;116(11):732-739. (Pubitemid 38622309)
122. Herrin J, Cangialose CB, Nicewander D, Ballard DJ. Cost and effects of performance feedback and nurse case management for Medicare beneficiaries with diabetes: a randomized controlled trial. Dis Manag. 2007;10(6): 328-336.
123. Haskell WL, Berra K, Arias E, et al. Multifactor cardiovascular disease risk reduction in medically underserved, high-risk patients. Am J Cardiol. 2006;98(11): 1472-1479. (Pubitemid 44779477)
124. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159(10):1104-1109. (Pubitemid 29230863)
125. Canadian Hypertension Education Program. 2008 Canadian Hypertension Education Program recommendations: the scientific summary - an annual update. Canadian Hypertension Society [pdf]. http://www.hypertension.ca/chep/ recommendations/diagnosis-assessment/accurate-measurement-of-blood-pressure/. Accessed October 2008.
126. Van Zuilen AD, Wetzels JF, Blankestijn PJ, et al. Rationale and design of the MASTERPLAN study: multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. J Nephrol. 2005;18(1):30-34. (Pubitemid 40723750)
127. Koelewijn-van Loon MS, van Steenkiste B, Ronda G, et al. Improving Patient Adherence to Lifestyle Advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care (protocol). BMC Health Serv Res. 2008;8:15.
128. Rose SB, Lawton BA, Elley CR, Dowell AC, Fenton AJ. The 'Women's Lifestyle Study,' 2-year randomized controlled trial of physical activity counselling in primary health care: rationale and study design. BMC Public Health. 2007;7:166.
129. McLean G, Tobias M. The New Zealand Physical Activity Questionnaires. Report on the Validation and Use of the NZPAQLF and NZPAQ-SF Self-report Physical Activity Survey Instruments. Wellington, New Zealand: Sport and Recreation New Zealand (SPARC); 2004.
130. McHorney CA,Ware JE Jr, Raczek AE. TheMOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247-263.
131. Jansink R, Braspenning J, van der Weijden T, Niessen L, Elwyn G, Grol R. Nurse-led motivational interviewing to change the lifestyle of patients with type 2 diabetes (MILD-project): protocol for a cluster, randomized, controlled trial on implementing lifestyle recommendations. BMC Health Serv Res. 2009;9:19.
132. Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52(1):1-9.
133. Bodenheimer T, MacGregor K, Stothart N. Nurses as leaders in chronic care. BMJ. 2005;330(7492):612-613. (Pubitemid 40444754)
134. Clark AM, Hartling L, Vandermeer B, Lissel SL, McAlister FA. Secondary prevention programmes for coronary heart disease: a meta-regression showing the merits of shorter, generalist, primary care-based interventions. Eur J Cardiovasc Prev Rehabil. 2007;14(4): 538-546. (Pubitemid 47229736)
135. Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005; 143(9):659-672.
136. McAlister FA, Lawson FM, Teo KK, Armstrong PW. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ. 2001; 323(7319):957-962. (Pubitemid 33016042)
137. Health Resources and Services Administration US Department of Health and Human Services Administration. The registered nurse population: findings from the 2004 national sample survey of registered nurses. http:// bhpr.hrsa.gov/healthworkforce/rnsurvey04/3.htm. Accessed December 14, 2009.
138. Berra K, Klieman L. National Cholesterol Education Program: Adult Treatment Panel III - new recommendations for lifestyle and medical management of dyslipidemia. J Cardiovasc Nurs. 2003;18(2):85-92.
139. Shaffer J, Wexler LF. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system. Results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care. Arch Intern Med. 1995;155(21):2330-2335.
140. Campbell NRC, Drouin D, Feldman R. A brief history of Canadian hypertension recommendations. Hypertens Can. 2005;(82):1-8.
141. Cardinal H, Monfared AA, Dorais M, LeLorier J. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue. Can J Cardiol. 2004;20(4):417-421. (Pubitemid 38578644)
142. Fonarow GC, Ballantyne CM. In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is now. Circulation. 2001;103(23): 2768-2770. (Pubitemid 32550059)
143. Schmittdiel JA, Uratsu CS, Karter AJ, et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23(5):588-594.
144. Herrin J, Nicewander DA, Hollander PA, et al. Effectiveness of diabetes resource nurse case management and physician profiling in a fee-for-service setting: a cluster randomized trial. Proc (Bayl Univ Med Cent). 2006;19(2): 95-102.
145. King AB, Wolfe GS. Evaluation of a diabetes specialist-guided primary care diabetes treatment program. J Am Acad Nurse Pract. 2009;21(1):24-30.
146. Lob SH, Kohatsu ND. Case management: a controlled evaluation of persons with diabetes. Clin Perform Qual Health Care. 2000;8(2):105-111. (Pubitemid 32514575)
147. Aubert RE, Herman WH, Waters J, et al. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Intern Med. 1998;129(8): 605-612.
148. Greving JP, Denig P, de Zeeuw D, Bilo HJ, Haaijer-Ruskamp FM. Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study. Cardiovasc Diabetol. 2007;6:25.
149. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326(7404): 1419.
150. Reddy KS. The preventive polypill-much promise, insufficient evidence. N Engl J Med. 2007;356(3):212. (Pubitemid 46143223)
151. Erdine S, Ro YM, Tse HF, et al. Single-pill amlodipine/ atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study). J Hum Hypertens. 2008;23(3):196-210.
152. Neutel JM, Bestermann WH, Dyess EM, et al. The use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter study. J Clin Hypertens (Greenwich). 2009;11(1):22-30.
153. Flack JM, Victor R, Watson K, et al. Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial. Mayo Clin Proc. 2008;83(1):35-45.
154. Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract. 2002;19(6):596-604. (Pubitemid 35460642)
155. Gutin B, Prince L, Stein R. Survey of cardiac rehabilitation centers in New York City. J Community Health. 1990;15(4):227-238. (Pubitemid 20296312)
156. Paez KA, Allen JK. Cost-effectiveness of nurse practitioner management of hypercholesterolemia following coronary revascularization. J Am Acad Nurse Pract. 2006;18(9): 436-444.
157. Kahn R, Robertson RM, Smith R, Eddy D. The impact of prevention on reducing the burden of cardiovascular disease. Circulation. 2008;118(5):576-585.
158. Bouchard MH, Dragomir A, Blais L, B2rard A, Pilon D, Perreault S. Impact of adherence to statins on coronary artery disease in primary prevention. Br J Clin Pharmacol. 2007;63(6):698-708. (Pubitemid 46753568)
159. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297(2):177-186. (Pubitemid 46089734)
160. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
161. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6): 521-530. (Pubitemid 40847288)
162. LaBresh KA, Fonarow GC, Smith SC Jr, et al. Improved treatment of hospitalized coronary artery disease patients with the Get With the Guidelines program. Crit Pathw Cardiol. 2007;6(3):98-105. (Pubitemid 47361012)
163. Foley KA, Vasey J, Berra K, Alexander CM, Markson LE. The Hyperlipidemia: Attitudes and Beliefs in Treatment (HABIT) survey for patients: results of a validation study. J Cardiovasc Nurs. 2005;20(1):35-42.
164. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121(7): e46-e215.